Tags

Type your tag names separated by a space and hit enter

The Wuhan SARS-CoV-2-What's next for China.
J Med Virol. 2020 06; 92(6):546-547.JM

Links

PMC Free PDF

Authors+Show Affiliations

Lu H
Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Stratton CW
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Tang YW
Cepheid, Danaher Diagnostic Platform, Shanghai, China.

MeSH

Antiviral AgentsBetacoronavirusCOVID-19COVID-19 VaccinesChinaCommunicable Disease ControlCoronavirus InfectionsDisease ManagementDisease OutbreaksHumansPandemicsPneumonia, ViralSARS-CoV-2TravelViral Vaccines

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32115732

Citation

Lu, Hongzhou, et al. "The Wuhan SARS-CoV-2-What's Next for China." Journal of Medical Virology, vol. 92, no. 6, 2020, pp. 546-547.
Lu H, Stratton CW, Tang YW. The Wuhan SARS-CoV-2-What's next for China. J Med Virol. 2020;92(6):546-547.
Lu, H., Stratton, C. W., & Tang, Y. W. (2020). The Wuhan SARS-CoV-2-What's next for China. Journal of Medical Virology, 92(6), 546-547. https://doi.org/10.1002/jmv.25738
Lu H, Stratton CW, Tang YW. The Wuhan SARS-CoV-2-What's Next for China. J Med Virol. 2020;92(6):546-547. PubMed PMID: 32115732.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Wuhan SARS-CoV-2-What's next for China. AU - Lu,Hongzhou, AU - Stratton,Charles W, AU - Tang,Yi-Wei, Y1 - 2020/03/18/ PY - 2020/02/13/received PY - 2020/02/26/accepted PY - 2020/3/3/pubmed PY - 2020/7/1/medline PY - 2020/3/3/entrez SP - 546 EP - 547 JF - Journal of medical virology JO - J Med Virol VL - 92 IS - 6 SN - 1096-9071 UR - https://www.unboundmedicine.com/medline/citation/32115732/The_Wuhan_SARS_CoV_2_What's_next_for_China_ DB - PRIME DP - Unbound Medicine ER -